Ori Barzilai, MD
Spine Neurosurgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Primary and Metastatic Spinal Tumors
- Complex Reconstruction and Stabilization of the Spine
- Minimally Invasive Spine Surgery
About Me
- Director of Minimally Invasive Spine Oncology
I am a neurosurgeon who specializes in caring for people with primary spine tumors or cancer that has spread to the spine from other parts of the body. I have specialty training in using leading-edge surgical methods to treat spinal tumors and degenerative disorders. These include minimally invasive techniques, spinal endoscopy, image guidance, and robotics. Advanced approaches allow me to remove tumors with the highest level of precision while making the lowest impact on my patients’ quality of life.
Read more
As a member of MSK’s Multidisciplinary Spine Tumor Center, I work with a team of specialists, including radiation oncologists, interventional radiologists, pain specialists, rehabilitation specialists, and medical oncologists. Providing our patients with comprehensive care requires a true team approach. At MSK, our vast experience and expertise make us uniquely suited to do this. For example, by combining surgery with radiosurgery and targeted therapies, we have revolutionized the way we treat spine tumors. In some instances, we are even able to offer our patients surgical strategies that won’t require them to be admitted to the hospital.
I am also involved in clinical research to improve treatments for spine tumors. I am particularly focused on patient outcomes and developing new therapies and technologies. My current work involves looking for ways to make systemic therapies, such as immunotherapy, more effective in treating spine tumors.
A cancer diagnosis can cause a great deal of anxiety and uncertainty. The thought of having to undergo spinal surgery can make these concerns worse. When I meet with patients and their loved ones, I truly listen to them and hear their expectations, goals, and fears before we agree on a clear treatment plan together. I hope that after seeing me they feel safe, calm, and confident with their care team.
Outside of work, I enjoy spending time with my wife and children. We love to travel and go to the beach. I am an avid runner, a passionate soccer fan, and an unexceptional guitar player.
A spine neurosurgeon is a doctor with special training in surgery on the spine.
My Specialties
- Primary and Metastatic Spinal Tumors
- Complex Reconstruction and Stabilization of the Spine
- Minimally Invasive Spine Surgery
- Degenerative Spinal Disorders
- Endoscopic Spinal Surgery
- Intradural Tumors
- Tumors of the Spinal Cord
- Neurofibromatosis
- Schwannomatosis
Education
- MD, Tel Aviv University
Residencies
- Neurological Surgery – Tel Aviv Sourasky Medical Center
Awards and Honors
- Globus Spine Fellow Award (2017)
Fellowships
- Spine Oncology – Memorial Sloan Kettering Cancer Center
Board Certifications
- Neurological Surgery (Israel)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Barzilai sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Barzilai O, Laufer I, Yamada Y, Higginson DS, Schmitt AM, Lis E, Bilsky MH. Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease. J Clin Oncol. 2017 Jul 20;35(21):2419-2427.
Barzilai O, Laufer I, Robin A, Xu R, Yamada Y, Bilsky M. Hybrid Therapy for Metastatic Epidural Spinal Cord Compression: Technique for Separation Surgery and Spine Radiosurgery. Neurosurgery (suppl: Operative Neurosurgery)
Read more
Barzilai O, Amato MK, McLaughlin L, Reiner AS, Ogilvie SQ, Lis E, Yamada Y, Bilsky MH, Laufer I. Hybrid surgery–radiosurgery therapy for metastatic epidural spinal cord compression: A prospective evaluation using patient-reported outcomes. Neuro-Oncology Practice. 2017 Jul 22.
Barzilai O, Lidar Z, Constantini S, Salame K, Bitan-Talmor Y, Korn A. Continuous mapping of the corticospinal tracts in intramedullary spinal cord tumor surgery using an electrified ultrasonic aspirator. J Neurosurg Spine. 2017 Aug;27(2):161-168.
Sowash M, Barzilai O, Kahn S, McLaughlin L, Boland P, Bilsky MH, Laufer I. Clinical outcomes following resection of giant spinal schwannomas: a case series of 32 patients. J Neurosurg Spine. 2017 Apr;26(4):494-500.
Visit PubMed for a full listing of Dr. Barzilai’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ori Barzilai discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].